Azilect (rasagiline) as an add-on therapy to Requip (ropinrole) improved sleep, reduced the need for sleep medications, and…
Articles by Steve Bryson, PhD
A new app called NMS Assist, designed to remotely monitor the non-motor symptoms of Parkinson’s disease, is being developed…
ABBV-951, a continuous infusion formulation of levodopa/carbidopa, brought comparable levels of levodopa into the bloodstream of healthy volunteers as surgically…
Anavex 2-73 (blarcamesine), an investigational oral therapy for Parkinson’s disease dementia, led to clinically meaningful improvements within all…
Offering more weekly exercise classes at a higher intensity over a wider geographical area may help to instill  better exercise habits…
A modified form of vitamin B3 called nicotinamide riboside (NR), taken as an oral supplement, increased levels of an energy…
Finger tapping data from Parkinson’s patients using smartphone screens were linked with disease severity in a large-scale analysis that…
In a final report on the Phase 2 AMBLED trial, scientists detailed the failure of Foliglurax (PTX002331) — once…
A low daily dose of aripiprazole, an antipsychotic therapy, significantly eased hallucinations and delusions in people with Parkinson’s disease and…
In an anonymous online survey, 11.3% of Norwegian adults with Parkinson’s disease revealed current or previous use of cannabis…